Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai announced the creation of the Center for Engineering and Precision Medicine (CEPM), one of the first U.S. centers to connect engineering science with medicine.
CEPM – at 619 West 54th Street in Manhattan, with research also at the Rensselaer campus in Troy, New York – is going to focus on research in neuroengineering, immunoengineering, and regenerative and reparative medicine. CEPM will also develop a five-year joint Ph.D. in engineering and precision medicine.
“This transformative partnership between Rensselaer and Icahn Mount Sinai recognizes that engineering and engineering science is fundamental to the understanding of biomedical phenomena and is essential to the development of the next generation of precision diagnostics and therapeutics, human health and well-being, and to the training of advanced researchers and physicians,” said Dr. Shirley Ann Jackson, president of Rensselaer Polytechnic Institute. “Innovative research is a foundation of Rensselaer, as our students, faculty, and graduates continue to change the world through scientific and technological advances. This center will continue to fuel medical and scientific discoveries with life-changing impacts across the globe.”
The RPI-Mount Sinai partnership has gotten over $70 million in shared research funding since 2013 with 90% of that from the National Institutes of Health.